Recent investigations have indicated that single nucleotide polymorphisms (SNPs) of the PPARGC1A gene may be associated with the susceptibility and progression of NAFLD, obesity, type 2 diabetes mellitus, and hypertension in various ethnicities [9,10]. The gene discussed is PPARGC1A; the disease is metabolic dysfunction-associated steatotic liver disease.